World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
58
Citations
11963
World Ranking
3524
National Ranking
84

Alexandre Harari publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Alexandre Harari sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 201 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Alexandre Harari D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Alexandre Harari sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Alexandre Harari is affiliated with the University of Lausanne in Switzerland. Their research spans multiple interconnected fields, primarily focusing on Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these areas, Harari's work touches on subfields such as Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Genetics.

The main themes of Harari's research include Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, vaccines and immunoinformatics approaches, T-cell and B-cell Immunology, Immune Cell Function and Interaction, and Monoclonal and Polyclonal Antibodies Research.

Harari has co-authored extensively with several researchers, including George Coukos, Sara Bobisse, Lana E. Kandalaft, Raphaël Genolet, and Michal Bassani-Sternberg. These collaborations account for many of their joint publications and contributions to advancing immunology and cancer research.

The most frequent venues publishing Harari's work include bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, Nature Communications, Nature Biotechnology, and Science Advances.

Key recent publications by Harari encompass the following:

  • Antitumour dendritic cell vaccination in a priming and boosting approach, 2020, Nature Reviews Drug Discovery
  • Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes, 2020, Nature Communications
  • Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer, 2021, Science Advances
  • T-cell repertoire analysis and metrics of diversity and clonality, 2020, Current Opinion in Biotechnology
  • Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting, 2021, Cell Reports Medicine

Best Publications

  • Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses

    Melissa L. Precopio;Michael R. Betts;Janie Parrino;David A. Price

  • Dominant TNF-α + Mycobacterium tuberculosis –specific CD4 + T cell responses discriminate between latent infection and active disease

    Alexandre Harari;Virginie Rozot;Felicitas Bellutti Enders;Matthieu Perreau

  • Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy.

    Alexandre Harari;Stéphanie Petitpierre;Florence Vallelian;Giuseppe Pantaleo

  • Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

    Janos L. Tanyi;Sara Bobisse;Eran Ophir;Sandra Tuyaerts

  • HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells

    Simone C. Zimmerli;Alexandre Harari;Cristina Cellerai;Florence Vallelian

  • An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.

    Alexandre Harari;Pierre-Alexandre Bart;Wolfgang Stöhr;Gonzalo Tapia

  • Functional Heterogeneity of Memory CD4 T Cell Responses in Different Conditions of Antigen Exposure and Persistence

    Alexandre Harari;Florence Vallelian;Pascal R. Meylan;Giuseppe Pantaleo

  • Functional signatures of protective antiviral T-cell immunity in human virus infections

    Alexandre Harari;Valérie Dutoit;Cristina Cellerai;Pierre‐Alexandre Bart

  • Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes.

    Chloe Chong;Chloe Chong;Markus Müller;HuiSong Pak;HuiSong Pak;Dermot Harnett

  • Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer

    Amélie Cachot;Mariia Bilous;Mariia Bilous;Yen-Cheng Liu;Xiaokang Li

  • Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes.

    Julien Racle;Justine Michaux;Georg Alexander Rockinger;Marion Arnaud

  • Standardization of cytokine flow cytometry assays

    Holden T Maecker;Aline Rinfret;Patricia D'Souza;Janice Darden

  • Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities

    Ruth McNerney;Markus Maeurer;Ibrahim Abubakar;Ibrahim Abubakar;Ben Marais

  • Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

    Jianda Yuan;Priti S. Hegde;Raphael Clynes;Periklis G. Foukas;Periklis G. Foukas

  • Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

    Giuseppe Pantaleo;Alexandre Harari

  • Antitumour dendritic cell vaccination in a priming and boosting approach

    Alexandre Harari;Alexandre Harari;Michele Graciotti;Michele Graciotti;Michal Bassani-Sternberg;Michal Bassani-Sternberg;Lana E Kandalaft;Lana E Kandalaft

  • Mycobacterium Tuberculosis-Specific CD8+ T Cells Are Functionally and Phenotypically Different Between Latent Infection and Active Disease

    Virginie Rozot;Selena Vigano;Jesica Mazza-Stalder;Elita Idrizi

  • Phenotypic heterogeneity of antigen‐specific CD4 T cells under different conditions of antigen persistence and antigen load

    Alexandre Harari;Florence Vallelian;Giuseppe Pantaleo

  • Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

    G. Paolo Rizzardi;Alexandre Harari;Brunella Capiluppi;Giuseppe Tambussi

  • Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

    Beatris Mastelic-Gavillet;Blanca Navarro Rodrigo;Laure Décombaz;Haiping Wang

  • Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.

    Fernanda G Herrera;Catherine Ronet;Maria Ochoa de Olza;David Barras

Frequent Co-Authors

Giuseppe Pantaleo
Giuseppe Pantaleo University of Lausanne
George Coukos
George Coukos Cornell University
Lana E. Kandalaft
Lana E. Kandalaft Ludwig Cancer Research
David Gfeller
David Gfeller University of Lausanne
Michal Bassani-Sternberg
Michal Bassani-Sternberg Ludwig Cancer Research
Philippe Guillaume
Philippe Guillaume University of Lausanne
Daniel E. Speiser
Daniel E. Speiser University of Lausanne
Ralf Wagner
Ralf Wagner University of Regensburg
Brian Stevenson
Brian Stevenson University of Kentucky
Thierry Calandra
Thierry Calandra University of Lausanne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge in immunology, pursuing related online degrees can open doors to diverse healthcare roles. Many students begin their journey with foundational nursing programs, including the best online RN programs for non nurses, which cater to individuals without prior nursing experience and provide a solid clinical base.

Accelerated programs, such as the accelerated FNP, are ideal for those aiming to fast-track their careers as Family Nurse Practitioners. These programs are designed to be completed in a shorter timeframe without compromising quality.

Transitioning to specialized roles like acute care is also an option. Nurses interested in advancing their skills can explore acute care nurse practitioner programs, which focus on managing complex patient conditions in hospital settings.

For prospective students seeking flexible entry points, some opt for the easiest accelerated nursing programs, which offer streamlined admissions while maintaining strong educational standards. These pathways are valuable for those balancing education with other commitments.

Best Scientists Citing Alexandre Harari

Trending Scientists

Recently Published Articles